Delong Chen - Publications

Corrigendum to "Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation" [Pharmacol. Res. 159 (2020) 104944].

Journal: Pharmacological research

Published: October 24, 2024

Arctiin alleviates knee osteoarthritis by suppressing chondrocyte oxidative stress induced by accumulated iron via AKT/NRF2/HO-1 signaling pathway.

Journal: Scientific reports

Published: May 17, 2024

Evaluating the efficacy of GIPR agonists on non-alcoholic fatty liver disease: A Mediation Mendelian Randomization Study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: March 06, 2024

Corrigendum: Inhibitory effects of Rhaponticin on osteoclast formation and resorption by targeting RANKL-induced NFATc1 and ROS activity.

Journal: Frontiers in pharmacology

Published: September 20, 2023

Cycloastragenol Attenuates Osteoclastogenesis and Bone Loss by Targeting RANKL-Induced Nrf2/Keap1/ARE, NF-κB, Calcium, and NFATc1 Pathways.

Journal: Frontiers in pharmacology

Published: November 06, 2021

12-Deoxyphorbol 13-acetate inhibits RANKL-induced osteoclastogenesis via the attenuation of MAPK signaling and NFATc1 activation.

Journal: International immunopharmacology

Published: May 03, 2021

The impacts of surgical mask in young healthy subjects on cardiopulmonary function and muscle performance: a randomized crossover trial.

Journal: Archives of public health = Archives belges de sante publique

Published: April 29, 2021

Inhibitory Effects of Rhaponticin on Osteoclast Formation and Resorption by Targeting RANKL-Induced NFATc1 and ROS Activity.

Journal: Frontiers in pharmacology

Published: December 22, 2020

Sanhuang Jiangtang tablet protects type 2 diabetes osteoporosis via AKT-GSK3β-NFATc1 signaling pathway by integrating bioinformatics analysis and experimental validation.

Journal: Journal of ethnopharmacology

Published: December 02, 2020

Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation.

Journal: Pharmacological research

Published: March 26, 2020

Hymenialdisine: A Marine Natural Product That Acts on Both Osteoblasts and Osteoclasts and Prevents Estrogen-Dependent Bone Loss in Mice.

Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

Published: November 01, 2019

Chinese herbal medicine formulas as adjuvant therapy for osteonecrosis of the femoral head: A systematic review and meta-analysis of randomized controlled trials.

Journal: Medicine

Published: September 12, 2018